Lysostaphin, from staphylococcus staphylolyticus

CAS : 9011-93-2

Ref. 3D-AL44846

Informations sur le produit

• Nom: Lysostaphin, from staphylococcus staphylolyticus
• Synonymes: Glycyl-glycine endopeptidase, Ambicin L, E.C. 3.4.24.75, Ec 3.4.24.75, Lysostaphin, Lysostaphin endopeptidase, Lysostaphin endopeptidases, Lysostaphin from Staphylococcus staphylolyticus

Description

Lysostaphin is a glycan with a terminal half-life of 2 hours. It is produced by Staphylococcus staphylolyticus and has been shown to have cell lysis activity. Lysostaphin binds to the penicillin-binding proteins in the bacterial cell wall, thereby inhibiting synthesis of the peptidoglycan layer and cell division. This drug also has high resistance to methicillin, tetracycline, and other antibiotics. The genome sequence of Lysostaphin shows that it contains signal peptide sequences at its N terminus and lysine residues at its C terminus. These features are important for its function as a protease enzyme that cleaves glycan chains from the cell wall of bacteria. Lysostaphin was found to be effective against methicillin-resistant Staphylococcus aureus (MRSA) strains and other antibiotic-resistant strains such as S. epidermidis with t

• Marque: Biosynth

Propriétés chimiques

• Degré de pureté: Min. 95%
• Couleur/Forme: Powder